Shanghai Obio Technology (Group) Corp., Ltd. (SHA:688238)
6.11
+0.03 (0.49%)
At close: Jun 2, 2026
SHA:688238 Market Cap
SHA:688238 has a market cap or net worth of 3.85 billion as of June 2, 2026. Its market cap has increased by 6.38% in one year.
Market Cap
3.85B
Enterprise Value
4.07B
Revenue
265.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.11
Market Cap Chart
Since March 22, 2022, SHA:688238's market cap has decreased from 10.81B to 3.85B, a decrease of -64.36%. That is a compound annual growth rate of -21.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 3.83B | -8.71% |
| Dec 31, 2025 | 4.20B | 30.93% |
| Dec 31, 2024 | 3.21B | -44.91% |
| Dec 29, 2023 | 5.82B | -38.08% |
| Dec 30, 2022 | 9.40B | -13.01% |
| Mar 22, 2022 | 10.81B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wuhan Hvsen Biotechnology | 4.29B |
| Beijing Scitop Bio-tech | 4.27B |
| Kexing Biopharm | 4.18B |
| Beijing Bohui Innovation Biotechnology Group | 4.16B |
| Hinova Pharmaceuticals | 4.06B |
| Hefei Lifeon Pharmaceutical | 3.86B |
| Shanghai Serum Bio-Technology | 3.84B |
| Boji Medical Technology | 3.83B |